期刊文献+

瑞芬太尼全凭静脉麻醉在支撑喉镜手术的应用 被引量:1

Clinical use of reminfentanil total intravenous anesthesia in patients undergoing suspensive laryngoscope
暂未订购
导出
摘要 目的:观察瑞芬太尼联合异丙酚全凭静脉麻醉在支撑喉镜声带息肉切除术中的麻醉效果。方法:择期行支撑喉镜声带息肉切除术的患者40例,ASAⅠ或Ⅱ级,术前检查均无重要脏器疾病史及药物过敏史。将40例患者随机分为2组,每组各20例:异丙酚-芬太尼全麻组为对照组(F组),异丙酚-瑞芬太尼全麻组为观察组(R组)。记录两组患者的心血管反应、苏醒拔管时间及苏醒质量。结果:①R组患者血流动力学变化比F组平稳(P<0.05);②R组患者苏醒拔管时间明显短于F组(P<0.05),拔管即刻及离开手术室送PACU时OAA/S评分R组明显高于F组(P<0.05)。结论:瑞芬太尼联合异丙酚全凭静脉麻醉在支撑喉镜声带息肉切除术,具有心血管反应轻、苏醒快等优点,是一种较理想的麻醉方法。 Objective:To evalute propofol with remifentanil during operation of suspension laryngoscopy.Methods:The elective laryngoscope polyp resection 40 patients,ASA Ⅰ or class Ⅱ,no vital organs preoperative medical history and drug allergies.The 40 patients were randomly divided into two groups,20 patients in each group:propofol-fentanyl anesthesia group as a control group(F group),propofol-remifentanil anesthesia group in the observation group(R group).Cardiovascular response to the two groups of patients,recovery time and wake up the quality of extubation.Results:① R hemodynamic changes in patients stable than the F group(P〈0.05);②R group were awake extubation time was significantly shorter than F group(P〈0.05),tracheal extubation,and PACU time to leave the operating room to send OAA/S Rated R was significantly higher than F group(P〈0.05).Conclusion:Remifentanil and propofol total intravenous anesthesia in the excision of vocal polyps laryngoscope,with the cardiovascular response to light,rapid recovery,etc.,is an ideal method of anesthesia.
出处 《中国当代医药》 2010年第31期69-70,共2页 China Modern Medicine
关键词 瑞芬太尼 支撑喉镜 声带息肉切除术 Remifentanil Laryngoscope Vocal cord polypectomy
  • 相关文献

参考文献7

二级参考文献31

  • 1陈利民,沈七襄,季蒙,姜加维,林武延.喉显微手术最佳麻醉方法的选择[J].中华麻醉学杂志,1997,17(3):179-180. 被引量:26
  • 2Feldman PL, James MK, Brackeen MF,et al. Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics. J Med Chem, 1991,34 : 2202-2208.
  • 3Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opiold: remifentanil (GI87084B). Anesth Analg, 1993, 77: 1031-1040.
  • 4Kapila A, Glass PS, Jacobs JR, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology,1995,83,968-975.
  • 5Hoke JF, Shlugman D, Dershwitz M, et al. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology, 1997,87:533-541.
  • 6Camu F, Royston D. Inpatient experience with remifentanil. Anesth Analg, 1999,89(Suppl 4): 15-21.
  • 7Glass PS, Gan TJ, Howell S .A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg, 1999,89: S7-S14.
  • 8James MK. Remifentanil and anesthesia for the future. Exp Opin Invest Drugs 1994,3:331-340.
  • 9Guy J, Hindman BJ, Baker KZ, et al. Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial spaceoccupying lesions. Anesthesiology, 1997,86:514-524.
  • 10Unlugenc H, Itegin M, Ocal I, et al. Remifentanil produces vasorelaxation in isolated rat thoracic aorta strips. Acta Anaesthesiol Scand,2003, 47:65-69.

共引文献651

同被引文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部